Critical Role of CD11a (LFA-1) in Therapeutic Efficacy of Systemically Transferred Antitumor Effector T Cells
Authors:
- Hiroshi KagamuHKHiroshi Kagamu
- Suyu ShuSSSuyu Shu
- Gregory E. PlautzGPGregory E. Plautz
- 1 March 1999
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 192 (2) , 122-132
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Expression of intercellular adhesion molecule‐3 (ICAM‐3/CD50) in malignant lymphoproliferative disorders and solid tumorsTissue Antigens, 1996
- Role of anti‐LFA‐1 and anti‐ICAM‐1 combined mab treatment in the rejection of tumors induced by moloney murine sarcoma virus (M‐MSV)International Journal of Cancer, 1995
- Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.Journal of Experimental Medicine, 1992
- A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture.Journal of Cell Biology, 1991
- Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.Journal of Experimental Medicine, 1991
- The T Lymphocyte in Experimental Allergic EncephalomyelitisAnnual Review of Immunology, 1990
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987
- Immune Responses in the Central Nervous SystemToxicologic Pathology, 1987
- Cellular immune reactivity within the CNSTrends in Neurosciences, 1986
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981